Comparing Subcutaneous and Intramuscular Injection of Merional in IVF
Author Information
Author(s): Alviggi Carlo, Revelli Alberto, Anserini Paola, Ranieri Antonio, Fedele Luigi, Strina Ida, Massobrio Marco, Ragni Nicola, De Placido Giuseppe
Primary Institution: Federico II University, Napoli, Italy
Hypothesis
Is subcutaneous administration of Merional as effective and tolerable as intramuscular administration in women undergoing IVF?
Conclusion
Subcutaneous injections of Merional are as effective as intramuscular injections for retrieving oocytes in IVF, with better tolerability.
Supporting Evidence
- No significant difference in the mean number of collected oocytes between the two groups.
- Both pregnancy rates were comparable between subgroups.
- Pain at injection site was reported only in the intramuscular group.
Takeaway
This study looked at two ways to give a medicine to help women get pregnant. It found that one way is just as good as the other, but the easier way hurts less.
Methodology
This was a prospective, controlled, randomised, parallel group open label, multicenter, phase III equivalence study involving 168 women undergoing IVF.
Potential Biases
Potential bias due to the non-blinding of patients and doctors regarding the administration route.
Limitations
The study had a limited sample size and was not fully blinded.
Participant Demographics
Normogonadotropic women aged 20-40 with normal ovulatory cycles.
Statistical Information
P-Value
p<0.01 for total hMG dose; p<0.05 for stimulation length.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website